Don't want ads? Subscribe or login now.

IRS Anti-Inversion Rule That Sank Pfizer Deal Struck Down

By Vidya Kauri · October 1, 2017, 8:14 AM EDT

A Texas federal court on Friday invalidated the anti-inversion rule that sank a planned $160 billion merger between Pfizer Inc. and Irish counterpart Allergan PLC, saying it was unlawfully implemented without...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Chamber of Commerce of the United States of America et al v. Internal Revenue Service et al

Case Number

1:16-cv-00944

Court

Texas Western

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 04, 2016

Recent Articles By Vidya

June 21, 2019
Private Cos. Face Higher Costs In Tax Disclosure Proposals
June 18, 2019
IRS Aims To Fix Error Slanting Farm Sales Toward Co-Ops
June 14, 2019
A New Tax Strategy For Multinationals: Shunning Tax Havens
June 11, 2019
No Tax On $4M Gain For Greek Mining Co., DC Circ. Affirms
June 07, 2019
9th Circ. Again Revives IRS Cost-Sharing Rule In Altera Row
May 24, 2019
DC Circ. Denies $33M Deduction For Land Gift To U Of Mich.
May 22, 2019
Executive Privilege A Poor Shield For Trump's Tax Docs
May 17, 2019
High Court Plea Could Undermine Tax Laws Lacking Regs
May 15, 2019
10th Circ. Denies Deductions For Benefit Plan Expenses
May 13, 2019
Attys Back Biz Owner's High Court Plea To Refuse Subpoenas